GnRH antagonists (Merck & Co)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGnRH antagonists (Merck & Co)
Drug Alias NameLHRH antagonists (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor antagonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsEndometriosisInfertilityNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsEndometriosisInfertilityNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A